3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Hemangiosarcoma
1
Breast Neoplasms
1
Interventions
Specimen Handling
113
Magnetic Resonance Spectroscopy
113
Cyclophosphamide
106
pembrolizumab
82
Radiotherapy
79
Nivolumab
68
Cisplatin
67
fludarabine
64
Carboplatin
59
Biopsy
54
Standard of Care
46
Radiosurgery
43
Gemcitabine
43
Paclitaxel
42
Dexamethasone
41
Rituximab
37
Radiation
37
Doxorubicin
37
Blood Specimen Collection
37
Cytarabine
36
Bevacizumab
35
venetoclax
34
fludarabine phosphate
33
Surveys and Questionnaires
32
Temozolomide
31
Radiotherapy, Intensity-Modulated
31
Capecitabine
31
Practice Guidelines as Topic
28
Etoposide
28
Oxaliplatin
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
ARX788
×
30 days
×
Clear all
NCT01042379
2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled